Therapeutic targeting of NF-κB in acute lung injury: a double-edged sword

MW Millar, F Fazal, A Rahman - Cells, 2022 - mdpi.com
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a devastating disease
that can be caused by a variety of conditions including pneumonia, sepsis, trauma, and most …

[PDF][PDF] Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis

J May, JA Mitchell, RG Jenkins - Journal of Clinical …, 2023 - Am Soc Clin Investig
Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor
survival. The incidence and mortality of IPF are rising, but treatment remains limited …

Vascular smooth muscle cell dysfunction in neurodegeneration

G Hayes, J Pinto, SN Sparks, C Wang, S Suri… - Frontiers in …, 2022 - frontiersin.org
Vascular smooth muscle cells (VSMCs) are the key moderators of cerebrovascular dynamics
in response to the brain's oxygen and nutrient demands. Crucially, VSMCs may provide a …

[HTML][HTML] Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial Hypertension

S Dhoble, V Patravale, E Weaver, DA Lamprou… - International Journal of …, 2022 - Elsevier
Abstract Pulmonary Arterial Hypertension (PAH) is the progressive increase in mean
pulmonary arterial pressure (mPAP)(≥ 20 mmHg at rest). Current treatment strategies …

Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular function

T Sawma, A Shaito, N Najm, M Sidani, A Orekhov… - Atherosclerosis, 2022 - Elsevier
Cardiovascular disease (CVD) continues to be the primary cause of global mortality.
Vascular smooth muscle cells (VSMCs) are integral components of vascular structure and …

[HTML][HTML] Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review

L Cui, T Yuan, Z Zeng, D Liu, C Liu, J Guo… - Biomedicine & …, 2022 - Elsevier
Pulmonary hypertension (PH) is a chronic and fatal disease, for which new therapeutic
drugs and approaches are needed urgently. Baicalein and baicalin, the active compounds …

Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension

E Mirhadi, P Kesharwani, TP Johnston… - Drug Discovery Today, 2023 - Elsevier
Highlights•Nanomedicine has emerged as a field with great opportunities to improve
treatment strategies.•Pulmonary arterial hypertension (PAH) is a serious and incurable …

Rutin Inhibits the Progression of Osteoarthritis Through CBS-Mediated RhoA/ROCK Signaling

C Sui, Y Wu, R Zhang, T Zhang, Y Zhang, J Xi… - DNA and Cell …, 2022 - liebertpub.com
Osteoarthritis (OA) is a chronic joint disease characterized by the deterioration of cartilage
and subchondral bone in the joints. Currently, there is no complete cure for OA, only …

Divergent roles of ephrin-B2/EphB4 guidance system in pulmonary hypertension

S Crnkovic, S Rittchen, K Jandl, J Gindlhuber… - …, 2023 - Am Heart Assoc
Background: Smooth muscle cell (SMC) expansion is one key morphological hallmark of
pathologically altered vasculature and a characteristic feature of pulmonary vascular …

Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells)

J Nahar, V Boopathi, M Murugesan, EJ Rupa, DC Yang… - Molecules, 2022 - mdpi.com
Ginsenoside Rh1 (G-Rh1), a possible bioactive substance isolated from the Korean Panax
ginseng Meyer, has a wide range of pharmacological effects. In this study, we have …